European Medicines Agency loses bid to end London lease over Brexit By Reuters

© Reuters. The headquarters of the European Medicines Agency (EMA), is seen in London

© Reuters. The headquarters of the European Medicines Agency (EMA), is seen in London

TedsWoodworking Plans and Projects

LONDON (Reuters) – The European Medicines Agency (EMA) has lost its bid to void a lease on its office in London’s Canary Wharf financial district due to Brexit, after a judge in London on Wednesday ruled in favor of property company Canary Wharf Group.

The EMA had argued Britain’s forthcoming exit from the European Union was an unexpected event that “frustrated” its 25-year lease on a building in Canary Wharf, meaning the European agency would no longer be bound to the lease.

The landmark ruling is likely to have wider implications, lawyers have said, as other tenants could have used it to try to escape from leases in Britain.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Source link


Please enter your comment!
Please enter your name here